Akebia Therapeutics
AKBA
AKBA
90 hedge funds and large institutions have $16.5M invested in Akebia Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $20.2M → $16.5M (-$3.69M)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
47% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 32
Holders
90
Holding in Top 10
1
Calls
$292K
Puts
$47K
Top Buyers
| 1 | +$485K | |
| 2 | +$400K | |
| 3 | +$154K | |
| 4 |
Two Sigma Investments
New York
|
+$102K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$101K |
Top Sellers
| 1 | -$973K | |
| 2 | -$593K | |
| 3 | -$322K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$304K |
| 5 |
E
Ergoteles
New York
|
-$215K |